This review aimed to summarise the relative risk (RR) of the main symptoms of long COVID
in people infected with SARS-CoV-2 compared to uninfected controls, as well as the …

Objective Although complications and clinical symptoms of COVID-19 have been elucidated,
the prevalence of long-term sequelae of COVID-19 is less clear in previously hospitalized …

Coronavirus 2 is responsible for Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-
CoV-2), and the main sequela is persistent fatigue. Post-viral fatigue is common and affects …

Die Deutsche Gesellschaft für Pneumologie hat 2021 die AWMF S1-Leitlinie Long-/Post-
COVID initiiert. In einem breiten interdisziplinären Ansatz wurde diese S1-Leitlinie …

Objectives Fatigue is a pervasive clinical symptom in coronaviruses and may continue
beyond the acute phase, lasting for several months or years. This systematic review and …

Fatigue was a commonly reported sequala after COVID-19. However, there is little literature
about the prevalence and predictors of fatigue one year after Intensive Care Unit (ICU) …

Background Fifteen percent of patients with cancer experience symptomatic sequelae,
which impair post–COVID-19 outcomes. In this study, we investigated whether a …

Abstract" Long COVID" is a term used to describe a condition when the symptoms and signs
associated with coronavirus disease 2019 (COVID-19) persist for more than three months …

Objective: The aim of this study was to investigate the association between serological
biomarkers at the acute phase of infection at hospital admission with the development of …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), later renamed coronavirus
disease 2019 (COVID-19), was first identified in Wuhan, China, in early December 2019 …